https://sudonull.com/remove-one-analysis-for-kpi-breakdown-of-event-contributions
Learn how to decompose aggregated KPI into contributions of individual procurements using remove-one. Fixing mode, metric nonlinearity. For analysts and developers. Read details.
https://sudonull.com/nano-diodes-sensor-memory-and-processing-in-one-element
Scientists created a p-n diode the size of a nanowire, combining photodetection, data storage, and processing. Learn how this will change electronics for IoT and wearable devices. Read the analysis of implications.
https://sudonull.com/fem-accuracy-comparison-of-scad-lira-and-ammonit3d
Comparison of SCAD++, Lira, and ammonit3d accuracy on a test with one finite element. Learn how the cloud solution combines analytical accuracy and modern visualization.
https://sudonull.com/ai-agents-for-one-person-companies-in-china
Learn how AI agents Accio Work and OpenClaw allow launching a business without staff. OPC growth in China: 30–40% of Alibaba customers. Automation details for developers.
https://sudonull.com/samsung-accused-of-planned-obsolescence-for-galaxy-s23-airdrop-blocked
Samsung blocked AirDrop on Galaxy S23 via update, although the chip supports the feature. Pirate firmware enables it. Read how not to pay for S25 in vain.
https://lrivo.com/iraola-among-bournemouth-s-best-managers-cook
Steve Cook calls Andoni Iraola one of Bournemouth's greatest managers ahead of his expected summer exit. Discover why his legacy matters.
https://lrivo.com/nico-paz-real-madrid-target-among-serie-a-s-most-valuable-at-21
Discover how Nico Paz became one of Serie A's top-valued players at 21 and why Real Madrid plans his return. Read about his impact at Como now.
https://lrivo.com/julia-n-alvarez-stats-trophies-transfer-rumors-2026
Discover why Julián Alvarez is one of football's most underrated stars. Full trophy list, 2026 World Cup role, and latest transfer rumors. Read now.
https://lrivo.com/man-utd-s-ugarte-a-transfer-to-forget
Explore why Man Utd's £50m signing of Manuel Ugarte is considered one of the worst transfers in the club's history. Learn more now.
https://ymaho.com/dtek-to-build-europe-s-largest-wind-farm-for-1-2-billion
DTEK announced the construction of a wind power plant with a capacity of 650 MW and a cost of €1.2 billion. The project will become one of the largest onshore wind farms in Europe. Find out how this will affect the energy market of Ukraine and Europe.
https://ymaho.com/btc-e-what-happened-to-the-customers-money-vinnik-s-answer
Alexander Vinnik explained where BTC-e users' funds went and how they can be recovered. Learn the truth about the fate of one of the most mysterious crypto exchanges.
https://lrivo.com/saibari-s-60m-valuation-psv-s-rising-star
PSV manager Peter Bosz has set a staggering €60 million+ price tag on midfielder Ismael Saibari. Discover why he's one of Europe's hottest transfer targets.
https://ymaho.com/tether-freezes-344m-usdt-after-u-s-authorities-flag-wallets
Tether froze over $344 million in USDT on Tron after U.S. authorities flagged wallets for illicit activity. One of the largest stablecoin freezes ever.
https://lrivo.com/union-berlin-supports-first-female-manager-in-top-league
Union Berlin stands firm against sexism, supporting Marie-Louise Eta, the first female manager in one of Europe's top five football leagues.
https://lrivo.com/bolton-crush-stevenage-to-boost-league-one-play-off-hopes
Bolton respond to Cardiff loss with 5-1 win over Stevenage. See how this result impacts their League One play-off chase and Championship promotion dream.
Priovant Announces Positive Phase 2 Results for Brepocitinib in ...
https://investor.roivant.com/news-releases/news-release-details/priovant-announces-positive-phase-2-results-brepocitinib
Feb 6, 2026 · Priovant plans to progress CS to a pivotal program with a Phase 3 study starting in calendar year 2026 following engagement with the FDA, representing the third indication with a …
Priovant Announces Positive Phase 2 Results for Brepocitinib in ...
https://www.sarkoidose-selbsthilfe.eu/imgs/Brepocitinib_Phase2_Haut.pdf
Priovant plans to progress CS to a pivotal program with a Phase 3 study starting in calendar year 2026 following engagement with the FDA, representing the third indication with a pivotal program for …
Priovant posts breakthrough Phase II data for brepocitinib in cutaneous ...
https://allsci.com/news/priovant-posts-breakthrough-phase-ii-data-for-brepocitinib-in-cutaneous-sarcoidosis/
Feb 9, 2026 · Priovant plans to initiate a Phase III program for brepocitinib in CS during calendar year 2026, following engagement with the US FDA. This represents the third indication for brepocitinib’s …
A Phase 2 Study of the Safety and Efficacy of Brepocitinib in Adults ...
https://clinicaltrials.gov/study/NCT06978725
The process of submitting and updating summary information about a clinical study and its protocol, from its beginning to end, to a structured, public Web-based study registry that is accessible to the public, …
Brepocitinib BEACON Phase 2: Topline Efficacy and Safety in Cutaneous ...
https://reachmd.com/news/brepocitinib-beacon-phase-2-topline-efficacy-and-safety-in-cutaneous-sarcoidosis/2485604/
Feb 9, 2026 · BEACON Phase 2 evaluated brepocitinib in cutaneous sarcoidosis and found a rapid improvement signal in lesion activity that is informing pivotal planning.
Priovant advances brepocitinib toward a third Phase 3 indication in ...
https://www.ncbiotech.org/news/priovant-advances-brepocitinib-toward-third-phase-3-indication-cutaneous-sarcoidosis
Feb 27, 2026 · “We are thrilled with the results of the BEACON study and are excited to rapidly move brepocitinib into Phase 3 development for cutaneous sarcoidosis,” said Ben Zimmer, Priovant CEO. …
Priovant's Brepocitinib Succeeds in Key Phase 2 Sarcoidosis Trial
https://www.edgen.tech/news/post/priovants-brepocitinib-succeeds-in-key-phase-2-sarcoidosis-trial
Feb 6, 2026 · Priovant Therapeutics announced positive Phase 2 results for its drug brepocitinib, marking the first successful industry-sponsored trial for the treatment of cutaneous sarcoidosis.
Brepocitinib Delivers Landmark Phase 2 Results in Cutaneous...
https://marketchameleon.com/articles/b/2026/2/6/brepocitinib-delivers-landmark-phase-2-results-in-cutaneous-sarcoidosis-roivant-solidifies-late-stage-pipeline-momentum
Feb 6, 2026 · Roivant's positive Phase 2 brepocitinib data in cutaneous sarcoidosis establishes a new clinical milestone for the field, paving the way for a pivotal Phase 3 program in 2026.
In trial, brepocitinib eases symptoms of sarcoidosis affecting skin
https://sarcoidosisnews.com/news/high-dose-brepocitinib-eases-symptoms-cutaneous-sarcoidosis-trial/
Feb 10, 2026 · Receiving a high dose of Priovant Therapeutics ’ oral treatment candidate brepocitinib in a clinical trial led to substantial reductions in symptom severity for all participants with cutaneous …
Roivant immune drug significantly outperformed placebo in ... - STAT
https://www.statnews.com/2026/02/06/roivant-immune-drug-significantly-outperformed-placebo-in-treating-rare-skin-disease/
Feb 6, 2026 · Roivant and its spinout Priovant said Friday that their immune-modifying drug brepocitinib significantly outperformed placebo in clearing lesions caused by a rare skin disease in a small trial.
Learn how to answer system design interview questions with a proven 5-step framework. Master scalability, trade-offs, and ace your next tech interview. Start now.
Learn how to design RESTful APIs for web applications with best practices on URIs, HTTP methods, versioning, and documentation. Build scalable, intuitive APIs that developers love.
Analysis of Global AI Trends 2026: Governance, Computing, Agentic AI, and Energy. Find out where the market is turning into the 'trough of disillusionment' and where it is accelerating. Read insights and forecasts.
SpaceX and KDDI launched satellite communication for smartphones in Japan. Learn how Starlink Direct-to-Cell works, who can access it, and what hidden geopolitical goals this project pursues.
Explore the complete history of the internet how it was created and evolved. From ARPANET to AI, discover key milestones and technological breakthroughs. Learn more today.
Chinese startup DeepWay announced a robotaxi with a range of 1000 km on solid-state batteries. Learn how this changes the electric vehicle market and why it matters.
Learn what are the ethical concerns in artificial intelligence, from bias to job loss. Backed by research, this guide offers a practical framework for evaluation.
Learn what is the difference between vpn and proxy, from encryption to scope. Discover which tool fits your privacy needs with our expert comparison.
Learn how does biotechnology use genetic engineering with CRISPR, gene therapy, and more. Explore breakthroughs in medicine, agriculture, and the future of DNA editing.
Learn how does quantum computing differ from classical computing. Compare bits vs qubits, strengths, use cases, and decide which paradigm fits your needs. Read now.